S

Sesen Bio Inc
F:PCBK

Watchlist Manager
Sesen Bio Inc
F:PCBK
Watchlist
Price: 0.5124 EUR 28.1% Market Closed
Market Cap: 103.9m EUR
Have any thoughts about
Sesen Bio Inc?
Write Note

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of PCBK.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PCBK Intrinsic Value
Not Available
S
Base Case Scenario
How do you feel about PCBK?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Sesen Bio Inc

Provide an overview of the primary business activities
of Sesen Bio Inc.

What unique competitive advantages
does Sesen Bio Inc hold over its rivals?

What risks and challenges
does Sesen Bio Inc face in the near future?

Show all valuation multiples
for Sesen Bio Inc.

Provide P/S
for Sesen Bio Inc.

Provide P/E
for Sesen Bio Inc.

Provide P/OCF
for Sesen Bio Inc.

Provide P/FCFE
for Sesen Bio Inc.

Provide P/B
for Sesen Bio Inc.

Provide EV/S
for Sesen Bio Inc.

Provide EV/GP
for Sesen Bio Inc.

Provide EV/EBITDA
for Sesen Bio Inc.

Provide EV/EBIT
for Sesen Bio Inc.

Provide EV/OCF
for Sesen Bio Inc.

Provide EV/FCFF
for Sesen Bio Inc.

Provide EV/IC
for Sesen Bio Inc.

Show me price targets
for Sesen Bio Inc made by professional analysts.

What are the Revenue projections
for Sesen Bio Inc?

How accurate were the past Revenue estimates
for Sesen Bio Inc?

What are the Net Income projections
for Sesen Bio Inc?

How accurate were the past Net Income estimates
for Sesen Bio Inc?

What are the EPS projections
for Sesen Bio Inc?

How accurate were the past EPS estimates
for Sesen Bio Inc?

What are the EBIT projections
for Sesen Bio Inc?

How accurate were the past EBIT estimates
for Sesen Bio Inc?

Compare the revenue forecasts
for Sesen Bio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sesen Bio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sesen Bio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sesen Bio Inc compared to its peers.

Compare the P/E ratios
of Sesen Bio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Sesen Bio Inc with its peers.

Analyze the financial leverage
of Sesen Bio Inc compared to its main competitors.

Show all profitability ratios
for Sesen Bio Inc.

Provide ROE
for Sesen Bio Inc.

Provide ROA
for Sesen Bio Inc.

Provide ROIC
for Sesen Bio Inc.

Provide ROCE
for Sesen Bio Inc.

Provide Gross Margin
for Sesen Bio Inc.

Provide Operating Margin
for Sesen Bio Inc.

Provide Net Margin
for Sesen Bio Inc.

Provide FCF Margin
for Sesen Bio Inc.

Show all solvency ratios
for Sesen Bio Inc.

Provide D/E Ratio
for Sesen Bio Inc.

Provide D/A Ratio
for Sesen Bio Inc.

Provide Interest Coverage Ratio
for Sesen Bio Inc.

Provide Altman Z-Score Ratio
for Sesen Bio Inc.

Provide Quick Ratio
for Sesen Bio Inc.

Provide Current Ratio
for Sesen Bio Inc.

Provide Cash Ratio
for Sesen Bio Inc.

What is the historical Revenue growth
over the last 5 years for Sesen Bio Inc?

What is the historical Net Income growth
over the last 5 years for Sesen Bio Inc?

What is the current Free Cash Flow
of Sesen Bio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sesen Bio Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Sesen Bio Inc

Balance Sheet Decomposition
Sesen Bio Inc

Current Assets 189.1m
Cash & Short-Term Investments 166.9m
Receivables 825k
Other Current Assets 21.4m
Non-Current Assets 30k
Other Non-Current Assets 30k
Current Liabilities 31m
Accounts Payable 1.2m
Accrued Liabilities 29.4m
Other Current Liabilities 354k
Efficiency

Earnings Waterfall
Sesen Bio Inc

Revenue
40m USD
Operating Expenses
-26.4m USD
Operating Income
13.6m USD
Other Expenses
-33.5m USD
Net Income
-19.9m USD

Free Cash Flow Analysis
Sesen Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PCBK Profitability Score
Profitability Due Diligence

Sesen Bio Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional 1-Year Revenue Growth
Positive 3-Year Average ROIC
Negative ROE
40/100
Profitability
Score

Sesen Bio Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

PCBK Solvency Score
Solvency Due Diligence

Sesen Bio Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
65/100
Solvency
Score

Sesen Bio Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PCBK Price Targets Summary
Sesen Bio Inc

There are no price targets for PCBK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PCBK?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PCBK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Sesen Bio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

103.9m EUR

Dividend Yield

0%

Description

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 35 full-time employees. The company went IPO on 2014-02-06. The firm's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process. The Company’s advanced product candidate Vicinium, also known as VB4-845, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of bacillus calmette-guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).

Contact

MASSACHUSETTS
Cambridge
245 1st St Ste 1800
+16174448550.0
sesenbio.com

IPO

2014-02-06

Employees

35

Officers

Pres, CEO & Director
Dr. Thomas R. Cannell D.V.M.
CFO & Treasurer
Ms. Monica Forbes
Chief Technology Officer
Dr. Glen C. MacDonald
Co-Founder
Dr. Gregory L. Verdine Ph.D.
Corp. Controller & Principal Accounting Officer
Ms. Elly Ryu
VP of Corp. Strategy & Investor Relations
Ms. Erin Clark
Show More
Gen. Counsel, Chief Compliance Officer & Corp. Sec.
Mr. Mark R. Sullivan
VP of Market Access
Mr. Steve Barbera
Sr. VP of Clinical Devel.
Dr. David Brooks
Chief Medical Officer
Dr. Dennis Kim M.D., MPH
Show Less

See Also

Discover More